Securities

HANWHA LIFE INSURANCE, RFHIC CORPORATION, AROMATICA CO. [Hana Securities’ Weekly Stock Picks]

KIM YOON-JEONG
2026-09-05 07:00:06
[Edaily Reporter KIM YOON-JEONG ] △HANWHA LIFE INSURANCE(088350)
- Profitability of new policies significantly improved through a shift in the product portfolio toward medium- to long-term whole life insurance
-Uncertainty regarding shareholder returns is expected to ease following improvements to the surrender value reserve system
Hana Securities CI. (Source: Hana Securities)

△RFHIC CORPORATION(218410)
-Profit growth continues, driven by expanding defense sales and strong performance in RF Materials
-The U.S. Upper C-band spectrum auction and the resumption of domestic 5G SA and 6G investments are driving medium- to long-term growth momentum
△#AROMATICA CO.
- Global revenue is expected to continue growing rapidly, driven by surging sales on Amazon and the expansion of offline channels in North America
-High product competitiveness driven by in-house production and R&D, along with an expanding share of overseas sales, serve as drivers of mid- to long-term growth

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

Jeong Yong-jin Starts by Replacing E-MART Co., Ltd.’s CEO… Appoints Entire Executive Team in Their 40s

Shinsegae Co.,Ltd Chairman Chung Yong-jin is returning to the forefront of management at E-MART Co., Ltd.(139480). Unlike in 2013, when he stepped down as a registered director and entrusted the busin…
2026-10-23 14:55:06

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02